---
title: Immunic Hopes for Trial Results in 2020
description: Immunic Hopes for Trial Results in 2020
---

[News ](https://www.yourway.com/news)

# [Immunic Hopes for Trial Results in 2020](https://www.yourway.com/news/immunic-hopes-for-trial-results-in-2020)

 Written by [Yourway](https://www.yourway.com/news/author/yourway) | June 25, 2020

Immunic has commenced phase II CALVID-1 clinical trials of their [IMU-838 therapy](https://www.clinicaltrialsarena.com/news/immunic-dosing-covid-19-trial/) to treat patients with coronavirus. The U.S.-based biotech firm expects trial results later in the year. Yourway has the global capacity to transport sensitive trial materials and deliver trial material directly to patients.

[View full post](https://www.yourway.com/news/immunic-hopes-for-trial-results-in-2020)

```json
{
  "@context" : "http://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "Yourway"
  },
  "dateModified" : "2020-06-25T09:00:00.445Z",
  "datePublished" : "2020-06-25T09:00:00Z",
  "headline" : "Immunic Hopes for Trial Results in 2020",
  "image" : {
    "@type" : "ImageObject",
    "height" : 961,
    "url" : "https://f.hubspotusercontent30.net/hubfs/5402331/images/news_june/week4/iStock-627290560.jpg",
    "width" : 1440
  },
  "mainEntityOfPage" : "https://www.yourway.com/news/immunic-hopes-for-trial-results-in-2020",
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "height" : 60,
      "url" : "/hs/hsstatic/content_shared_assets/static-1.4092/img/default-amp-logo.png",
      "width" : 60
    },
    "name" : "News"
  }
}
```